T-Cell Suppression By Src/ABL Kinase Inhibitors When Combined with Blinatumomab in Ph plus Acute Lymphoblastic Leukemia

被引：0
|
作者：
Leonard, Jessica [1 ]
Kosaka, Yoko [2 ]
Malla, Pavani [3 ]
Hayes-Lattin, Brandon [4 ]
Lamble, Adam J. [5 ]
Druker, Brian J. [1 ]
Tyner, Jeffrey W. [6 ]
Chang, Bill H. [3 ]
Lind, Evan F. [7 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Microbiol & Immunol, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA
[5] Seattle Childrens Hosp, Hematol Oncol, Seattle, WA USA
[6] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA
[7] Oregon Hlth & Sci Univ, Microbiol & Immunol, Portland, OR 97201 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2694
引用
收藏
页数：4
相关论文
共 50 条
  • [21] CApSiZing T-cell acute lymphoblastic leukemia
    Mandleywala, Komal
    Herranz, Daniel
    HAEMATOLOGICA, 2024, 109 (06)
  • [22] Pediatric T-Cell Acute Lymphoblastic Leukemia
    Karrman, Kristina
    Johansson, Bertil
    GENES CHROMOSOMES & CANCER, 2017, 56 (02): : 89 - 116
  • [23] A model system to treat T-cell acute lymphoblastic leukemia with JAK inhibitors
    Senkevitch, Emilee
    Hixon, Julie
    Li, Wenqing
    Durum, Scott
    CANCER RESEARCH, 2015, 75
  • [24] Assessment of Molecular Response to Tyrosine Kinase Inhibitors in Tunisian Patients With Ph plus Acute Lymphoblastic Leukemia
    Frikha, Rim
    El Aoud, Amina
    Kamoun, Hassen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S237 - S237
  • [25] AKR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA - MODEL FOR HUMAN T-CELL LEUKEMIA
    BORTIN, MM
    TRUITT, RL
    BIOMEDICINE, 1977, 26 (05): : 309 - 311
  • [26] T-Cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia
    Mantadakis, Elpis
    Danilatou, Vassiliki
    Stiakaki, Eftichia
    Paterakis, George
    Papadhimitriou, Stefanos
    Kalmanti, Maria
    PEDIATRIC BLOOD & CANCER, 2007, 48 (03) : 354 - 357
  • [27] T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma: One disease or two?
    Raetz, EA
    Perkins, SL
    Bhojwani, D
    Carroll, WL
    Min, DJ
    BLOOD, 2003, 102 (11) : 578A - 578A
  • [28] Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia
    Bontoux, Christophe
    Simonin, Mathieu
    Garnier, Nathalie
    Lhermitte, Ludovic
    Touzart, Aurore
    Andrieu, Guillaume
    Bruneau, Julie
    Lengline, Etienne
    Plesa, Adriana
    Boissel, Nicolas
    Baruchel, Andre
    Bertrand, Yves
    Molina, Thierry Jo
    Macintyre, Elizabeth
    Asnafi, Vahid
    MODERN PATHOLOGY, 2022, 35 (09) : 1227 - 1235
  • [29] Overcoming Leukemia-Induced Immune Suppression in BCR-ABL plus Acute Lymphoblastic Leukemia
    Farrar, Michael
    Hekim, Can
    Luke, Manlove S.
    Vezys, Vaiva
    Jenkins, Marc K.
    BLOOD, 2017, 130
  • [30] IS IMMUNOGLOBULIN/T-CELL RECEPTOR MEASURABLE RESIDUAL DISEASE MONITORING TRULY INFORMATIVE IN PH plus ACUTE LYMPHOBLASTIC LEUKEMIA?
    Beldinanzi, M.
    Della Starza, I.
    Bellomarino, V.
    Cardinali, D.
    Elia, L.
    Matarazzo, M.
    Soscia, R.
    Cola, M.
    Di Trani, M.
    Foa, R.
    Chiaretti, S.
    HAEMATOLOGICA, 2024, 109 : 78 - 78
12345